Atsushi Fushimi

Also affiliated with Harvard University, Japan Anti Tuberculosis Association, Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer”.

MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer

Cancer Letters(2023)10.1016/j.canlet.2023.216116

N/A

0.731DataRank · unranked

22 citations

Nami Yamashita, Haruka Hirose, Atsushi Fushimi, Naoki Haratake, Tatsuaki Daimon +6 more

MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells

Oncogene(2021)10.1038/s41388-021-01899-y

N/A

0.646DataRank · unranked

73 citations

Atsushi Fushimi, Nami Yamashita, Atrayee Bhattacharya, Hasan Rajabi, Mark D. Long +5 more

MUC1-C drives stemness in progression of colitis to colorectal cancer

JCI Insight(2020)10.1172/jci.insight.137112

N/A

0.617DataRank · unranked

60 citations

Ning Zhang, Caining Jin, Mark D. Long, Hasan Rajabi, Yota Yasumizu +12 more

MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-22-0772

N/A

0.542DataRank · unranked

36 citations

Yoshihiro Morimoto, Atsushi Fushimi, Rehan Ahmad, Atrayee Bhattacharya, Tatsuaki Daimon +15 more

MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression

Communications Biology(2023)10.1038/s42003-023-05395-9

N/A

0.489DataRank · unranked

25 citations

Atsushi Fushimi, Keyi Wang, Nami Yamashita, Yoshihiro Morimoto, Satoshi Ishikawa +6 more

Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment

Oncogene(2022)10.1038/s41388-022-02361-3

N/A

0.449DataRank · unranked

19 citations

Atsushi Fushimi, Nami Yamashita, Masayuki Hagiwara, Atrayee Bhattacharya, Jingwei Cheng +11 more

MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas

Carcinogenesis(2021)10.1093/carcin/bgab097

N/A

0.434DataRank · unranked

17 citations

Yoshihiro Morimoto, Atsushi Fushimi, Nami Yamashita, Wenhao Suo, Atrayee Bhattacharya +4 more

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion

Cancer Cell(2024)10.1016/j.ccell.2024.10.013

N/A

0.416DataRank · unranked

15 citations

Anton Safonov, Catherine Jones, Enrico Moiso, Jonathan R. Dry, Hong Shao +22 more

Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non–neuroendocrine Small Cell Lung Cancer

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-22-0165

N/A

0.416DataRank · unranked

15 citations

Yoshihiro Morimoto, Satoshi Ishikawa, Nami Yamashita, Atrayee Bhattacharya, Tatsuaki Daimon +12 more

MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy

JCI Insight(2025)10.1172/jci.insight.190924

N/A

0.373DataRank · unranked

11 citations

Tatsuaki Daimon, Hiroshi Hongo, Sheng-Yu Ku, Hiroki Ozawa, Naoki Haratake +14 more

MUC1-C dependency in drug resistant HR+/HER2− breast cancer identifies a new target for antibody-drug conjugate treatment

npj Breast Cancer(2025)10.1038/s41523-025-00751-w

N/A

0.292DataRank · unranked

6 citations

Atrayee Bhattacharya, Hiroki Ozawa, Naoki Haratake, Keisuke Shigeta, Atsushi Fushimi +16 more

IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRESSION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0011

N/A

0.269DataRank · unranked

5 citations

Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang +13 more

MUC1-C auto-regulatory complex with EBNA1 is responsible for latent Epstein-Barr virus-associated gastric cancer progression

Oncogene(2025)10.1038/s41388-025-03519-5

N/A

0.241DataRank · unranked

4 citations

Yin Wang, Henry Withers, Naoki Haratake, Ayako Nakashoji, Atrayee Bhattacharya +14 more

MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells

iScience(2023)10.1016/j.isci.2023.108168

N/A

0DataRank · unranked

14 citations

Henry Withers, Yoshihiro Morimoto, Atrayee Bhattacharya, Naoki Haratake, Tatsuaki Daimon +8 more

MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells

Cancer Research(2020)10.1158/0008-5472.can-20-2588

N/A

0DataRank · unranked

80 citations

Yota Yasumizu, Nami Yamashita, Hasan Rajabi, Atsushi Fushimi, Mark D. Long +7 more

MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002115

N/A

0DataRank · unranked

81 citations

Mark D. Long, Atsushi Fushimi, Masaaki Yamamoto, Tsuyoshi Hata, Masayuki Hagiwara +6 more

MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0672

N/A

0DataRank · unranked

33 citations

Atsushi Fushimi, Nami Yamashita, Masayuki Hagiwara, Yoshihiro Morimoto, Hasan Rajabi +8 more

MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer

Nature Communications(2020)10.1038/s41467-019-14219-6

N/A

0DataRank · unranked

195 citations

Hasan Rajabi, Caining Jin, Tsuyoshi Hata, Sean P. Pitroda, Mark D. Long +18 more

MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006238

N/A

0DataRank · unranked

25 citations

Nami Yamashita, Tatsuaki Daimon, Haruka Hirose, Shizuka Yamano, Naoki Haratake +9 more

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion

Cancer Cell(2024)10.1016/j.ccell.2024.09.009

N/A

0DataRank · unranked

49 citations

Anton Safonov, Catherine Jones, Enrico Moiso, Jonathan R. Dry, Hong Shao +23 more